Company Search:
Advanced Search
Sponsored Links
Komipharm International Company Limited Company Snapshot
Komipharm International Company Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Komipharm International Company Limited with three other companies in this sector in South Korea: ISU Abxis Company Limited (2016 sales of 19.05 billion Korean Won [US$16.71 million] of which 98% was Antibody Medicine), Corestem Inc (17.95 billion Korean Won [US$15.74 million] of which 86% was The clinical trial agent), and Choong Ang Vaccine Laboratory (37.90 billion Korean Won [US$33.24 million] ).

Sales Analysis. Komipharm International Company Limited reported sales of 37.64 billion Korean Won (US$33.01 million) for the year ending December of 2016. This represents an increase of 3.4% versus 2015, when the company's sales were 36.41 billion Korean Won. Sales at Komipharm International Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 103%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Komipharm International Company Limited
  Stock Performance Chart for Komipharm International Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (8/18/2017): 37,800
(Figures in Korean Won)
1 Week 1.3%   13 Weeks -8.5%  
4 Weeks 5.9%   52 Weeks 16.7%  
Komipharm International Company Limited Key Data:
  Ticker: 041960 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 37,636,361,907
(Year Ending Jan 2017).
Employees: 155
  Currency: Korean Won Market Cap: 2,057,520,641,400
  Fiscal Yr Ends: December Shares Outstanding: 54,431,763
  Share Type: Common Closely Held Shares: 21,580,180
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.